Molecular Hydrogen Attenuates Chronic Inflammation and Delays the Onset of Ultraviolet B-Induced Skin Carcinogenesis in Mice.
Fumiko Hori, Sayaka Sobue, Chisato Inoue, Yoshiki Murakumo, Masatoshi Ichihara · International journal of molecular sciences · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In male HR-1 hairless mice, however, no significant difference was observed between the H₂ -treated and control groups, most likely due to the long-term accumulation of lipid oxidation products resulting from the high levels of ROS generated by weekly UVB irradiation over the 10 weeks. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in male HR-1 hairless mice. However, no significant difference was observed between the H₂ -treated and control groups, most likely due to the long-term accumulation of lipid oxidation products resulting from the high levels of ROS generated by weekly UVB irradiation over the 10 weeks.
What the Researchers Studied
The researchers studied male HR-1 hairless mice. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 2% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 2% source-reported H₂ gas concentration; 10 L/min total gas flow (approximately 200 mL/min H₂ component); reported treatment duration: 20 weeks. However, no significant difference was observed between the H₂ -treated and control groups, most likely due to the long-term accumulation of lipid oxidation products resulting from the high levels of ROS generated by weekly UVB irradiation over the 10 weeks. The authors concluded that continuous H₂ administration attenuates inflammation-associated early UVB carcinogenesis through modulation of the IL-6/STAT3 and ERK/JNK pathways, supporting its use as a chemopreventive approach. Prior in vivo studies further suggest that efficacy depends on the administration regimen; for instance, continuous 2% hydrogen gas inhalation produced only marginal effects, whereas intermittent 2% hydrogen gas exposure and HRW conferred clearer protection, consistent with a signal-modulating mechanism benefitting from repeated transient H₂ elevations [ 41 ].
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male HR-1 hairless mice. The study used a preclinical animal experiment. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 2% source-reported H₂ gas concentration. The reported treatment duration was 20 weeks.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.